Low-dose peginterferon alfa-2a (40kd) (Pegasys (R)) to treat hepatitis C-infected, end-stage renal disease patients undergoing haemodialysis: Final study results
Author
Alric, L.
Cheinquer, H.
Besisik, F.
Ferraz, M. Lucia
Samuel, D.
Messinger, D.
Peck-Radosavljevic, M.
Boletis, J.
Metadata
Show full item recordCollections
- Bildiri [64839]